2023 Q1 Form 10-K Financial Statement

#000143774923010425 Filed on April 17, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $1.322M $1.854M $7.599M
YoY Change -27.39% -4.55% 41.17%
Cost Of Revenue $681.0K $701.9K $2.985M
YoY Change -45.66% -28.87% 5.53%
Gross Profit $641.1K $1.152M $4.613M
YoY Change 12.96% 20.56% 80.66%
Gross Profit Margin 48.49% 62.15% 60.71%
Selling, General & Admin $741.8K $971.8K $3.881M
YoY Change 7.11% 79.31% 103.28%
% of Gross Profit 115.71% 84.32% 84.12%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.220K -$1.090K $100.1K
YoY Change -87.25% -102.33% -22.41%
% of Gross Profit 0.66% -0.09% 2.17%
Operating Expenses $741.8K $971.8K $3.881M
YoY Change 7.11% 79.31% 103.28%
Operating Profit -$100.7K $180.6K $732.4K
YoY Change -19.41% -56.36% 13.64%
Interest Expense $3.300K $3.300K
YoY Change -228.4% -86.71%
% of Operating Profit 1.83% 0.45%
Other Income/Expense, Net $0.00 $0.00 $628.3K
YoY Change -100.0% 121.4%
Pretax Income -$100.7K $183.9K $1.361M
YoY Change 223.35% -55.28% 46.58%
Income Tax $0.00 $60.00K $300.0K
% Of Pretax Income 32.62% 22.05%
Net Earnings -$100.7K $342.6K $1.247M
YoY Change 223.35% 57.45% 71.67%
Net Earnings / Revenue -7.62% 18.48% 16.41%
Basic Earnings Per Share -$0.10 $1.28
Diluted Earnings Per Share -$0.10 $0.34 $1.26
COMMON SHARES
Basic Shares Outstanding 976.3K 976.3K 976.0K
Diluted Shares Outstanding 995.6K 987.1K

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.149M $5.977M $5.977M
YoY Change 98.72% 144.27% 144.27%
Cash & Equivalents $6.149M $5.977M
Short-Term Investments
Other Short-Term Assets $215.1K $354.9K $354.9K
YoY Change 2.08% -29.82% -29.82%
Inventory $2.772K $13.55K $13.55K
Prepaid Expenses $215.1K $354.9K
Receivables $202.2K $244.5K $244.5K
Other Receivables $279.9K $279.9K $279.9K
Total Short-Term Assets $6.849M $6.870M $6.870M
YoY Change 49.84% 63.78% 63.78%
LONG-TERM ASSETS
Property, Plant & Equipment $38.65K $42.86K $42.86K
YoY Change -84.53% -84.08% -93.48%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00
YoY Change
Total Long-Term Assets $38.65K $42.86K $42.87K
YoY Change -97.19% -96.95% -96.95%
TOTAL ASSETS
Total Short-Term Assets $6.849M $6.870M $6.870M
Total Long-Term Assets $38.65K $42.86K $42.87K
Total Assets $6.888M $6.913M $6.913M
YoY Change 15.86% 23.4% 23.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $381.2K $328.5K $328.5K
YoY Change -23.18% 54.79% 54.8%
Accrued Expenses $594.4K $597.3K $597.3K
YoY Change 49.4% 47.63% 32.64%
Deferred Revenue $204.6K $204.6K
YoY Change 13.13% 153.01%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.180M $1.130M $1.130M
YoY Change 4.38% 50.18% 50.18%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.180M $1.130M $1.130M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.180M $1.130M $1.130M
YoY Change -21.35% -0.66% -0.66%
SHAREHOLDERS EQUITY
Retained Earnings -$14.16M -$14.06M
YoY Change -7.67% -8.14%
Common Stock $19.87M $19.84M
YoY Change 0.43% 0.36%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.707M $5.783M $5.783M
YoY Change
Total Liabilities & Shareholders Equity $6.888M $6.913M $6.913M
YoY Change 15.86% 23.4% 23.4%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$100.7K $342.6K $1.247M
YoY Change 223.35% 57.45% 71.67%
Depreciation, Depletion And Amortization $4.220K -$1.090K $100.1K
YoY Change -87.25% -102.33% -22.41%
Cash From Operating Activities $171.8K -$608.7K $1.713M
YoY Change -74.06% -264.81% 110.45%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $6.010K $15.69K
YoY Change -271.71% -80.76%
Acquisitions
YoY Change
Other Investing Activities $1.440M $1.440M
YoY Change
Cash From Investing Activities $0.00 $1.434M $1.424M
YoY Change -41071.43% -1846.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $0.00 437.2K $393.4K
YoY Change -100.0% 517.99% -313.35%
NET CHANGE
Cash From Operating Activities $171.8K -608.7K $1.713M
Cash From Investing Activities $0.00 1.434M $1.424M
Cash From Financing Activities $0.00 437.2K $393.4K
Net Change In Cash $171.8K 1.263M $3.530M
YoY Change -73.47% 189.16% 544.41%
FREE CASH FLOW
Cash From Operating Activities $171.8K -$608.7K $1.713M
Capital Expenditures $0.00 $6.010K $15.69K
Free Cash Flow $171.8K -$614.7K $1.697M
YoY Change -74.06% -264.87% 131.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001128281
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.04918 pure
CY2022 skas Sharebased Compensation Weighted Average Remaining Amortization Period
SharebasedCompensationWeightedAverageRemainingAmortizationPeriod
P5Y
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
80878 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
204633 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
46000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
328000 usd
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022 dei Auditor Name
AuditorName
Kronick Kalada Berdy & Co. P.C.
CY2022 dei Security12b Title
Security12bTitle
Common Stock, $0.03 par value
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
3277495 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
976330
CY2022 dei Auditor Location
AuditorLocation
Kingston, Pennsylvania
CY2022 dei Auditor Firm
AuditorFirmId
448
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5977157 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1647097 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
244543 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
209835 usd
CY2022Q4 skas Noncomplete Receivables Current
NoncompleteReceivablesCurrent
160000 usd
CY2021Q4 skas Noncomplete Receivables Current
NoncompleteReceivablesCurrent
0 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
13551 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
740 usd
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
119899 usd
CY2021Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
693578 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
354913 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
413792 usd
CY2022Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 usd
CY2021Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
1229673 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
6870063 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
4194715 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3111462 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3093877 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
42862 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
46407 usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
0 usd
CY2021Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
1360714 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
115303 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
80878 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
378468 usd
CY2022Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 usd
CY2021Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
178035 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1130400 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
752684 usd
CY2022Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
0 usd
CY2021Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
385243 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1130400 usd
CY2021Q4 us-gaap Liabilities
Liabilities
1137927 usd
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.03
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.03
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
333306
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
333306
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.03
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.03
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3333334
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3333334
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
976330
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
976330
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
975074
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
975074
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
29290 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
29252 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
19812794 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
19740837 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14059559 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15306180 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
5782525 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
4463909 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6912925 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5601836 usd
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7598597 usd
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2400316 usd
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2985281 usd
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
575362 usd
CY2022 us-gaap Gross Profit
GrossProfit
4613316 usd
CY2021 us-gaap Gross Profit
GrossProfit
1824954 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3880902 usd
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1384408 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
732414 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
440546 usd
CY2022 skas Life Insurance Gain Loss
LifeInsuranceGainLoss
500000 usd
CY2021 skas Life Insurance Gain Loss
LifeInsuranceGainLoss
0 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
304833 usd
CY2022 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
1060716 usd
CY2021 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
599159 usd
CY2022 us-gaap Discontinued Operation Amount Of Adjustment To Prior Period Gain Loss On Disposal Before Income Tax
DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalBeforeIncomeTax
-65413 usd
CY2021 us-gaap Discontinued Operation Amount Of Adjustment To Prior Period Gain Loss On Disposal Before Income Tax
DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalBeforeIncomeTax
179125 usd
CY2022 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
431318 usd
CY2021 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
0 usd
CY2022 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
180000 usd
CY2021 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
52100 usd
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.26
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1023709
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
3907732 usd
CY2021 skas Amortization Of Deferred Stock Based Compensation
AmortizationOfDeferredStockBasedCompensation
34392 usd
CY2021 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
204399 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
726184 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
4463909 usd
CY2022 skas Amortization Of Deferred Stock Based Compensation
AmortizationOfDeferredStockBasedCompensation
71995 usd
CY2022 skas Adjustment To Additional Paid In Capital Issuance Of Additional Common Stock
AdjustmentToAdditionalPaidInCapitalIssuanceOfAdditionalCommonStock
-0 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
1246621 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
5782525 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
1246621 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
726184 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
100089 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
128990 usd
CY2022 skas Life Insurance Gain Loss
LifeInsuranceGainLoss
500000 usd
CY2021 skas Life Insurance Gain Loss
LifeInsuranceGainLoss
-0 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
71995 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
34392 usd
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
431318 usd
CY2021 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-0 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-0 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
304833 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-60866 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
43308 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-7091 usd
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
79485 usd
CY2022 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-573679 usd
CY2021 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-261922 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-150805 usd
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
248089 usd
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
123755 usd
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
2512 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
116284 usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
150200 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
192689 usd
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
185266 usd
CY2022 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
465935 usd
CY2021 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
87567 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1712556 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
813751 usd
CY2022 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1440000 usd
CY2021 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15685 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
81544 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1424315 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-81544 usd
CY2022 skas Purchase And Cancellation Of Common Stock Total
PurchaseAndCancellationOfCommonStockTotal
0 usd
CY2021 skas Purchase And Cancellation Of Common Stock Total
PurchaseAndCancellationOfCommonStockTotal
-204399 usd
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
CY2021 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
76000 usd
CY2022 skas Proceeds From Life Insurance Policy Classified As Financing Activities
ProceedsFromLifeInsurancePolicyClassifiedAsFinancingActivities
500000 usd
CY2021 skas Proceeds From Life Insurance Policy Classified As Financing Activities
ProceedsFromLifeInsurancePolicyClassifiedAsFinancingActivities
0 usd
CY2022 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
67045 usd
CY2021 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
8955 usd
CY2022 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
39575 usd
CY2021 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
47029 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
393380 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-184383 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3530251 usd
CY2022 us-gaap Notes Issued1
NotesIssued1
160000 usd
CY2021 us-gaap Notes Issued1
NotesIssued1
0 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
17979 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
24823 usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
216546 usd
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
8364 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5977157 usd
CY2022Q4 skas Working Capital
WorkingCapital
5739663 usd
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7598597 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
1246621 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1712556 usd
CY2022 skas Incremental Common Shares Attributable To Options And Warrants
IncrementalCommonSharesAttributableToOptionsAndWarrants
11101
CY2021 skas Incremental Common Shares Attributable To Options And Warrants
IncrementalCommonSharesAttributableToOptionsAndWarrants
3020
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
987149
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1026729
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
26664
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
36663
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1424315 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
393380 usd
CY2015 skas Environmental Remediation Agreed Percentage Of Reduction In Tenant Operated Tourist Flights
EnvironmentalRemediationAgreedPercentageOfReductionInTenantOperatedTouristFlights
0.20 pure
CY2015 skas Environmental Remediation Agreed Percentage Of Reduction In Tenant Operated Tourist Flights By Year One
EnvironmentalRemediationAgreedPercentageOfReductionInTenantOperatedTouristFlightsByYearOne
0.40 pure
CY2015 skas Environmental Remediation Agreed Percentage Of Reduction In Tenant Operated Tourist Flights By Year Two
EnvironmentalRemediationAgreedPercentageOfReductionInTenantOperatedTouristFlightsByYearTwo
0.50 pure
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2138000 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
0 usd
CY2022 skas Concession Fees
ConcessionFees
1509000 usd
CY2021 skas Concession Fees
ConcessionFees
192000 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<span style="text-decoration: underline; ">Use of Estimates</span>The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s significant estimates include depreciation, amortization, impairment of goodwill and intangibles, stock-based compensation, allowance for doubtful accounts, deferred tax assets, and contingent liabilities.
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
387000 usd
CY2022 us-gaap Advertising Expense
AdvertisingExpense
0 usd
CY2021 us-gaap Advertising Expense
AdvertisingExpense
3000 usd
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
976048
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1023709
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
71995 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
34392 usd
CY2022 skas Shares Based Compensation Stock Options Unamortized Fair Value
SharesBasedCompensationStockOptionsUnamortizedFairValue
76000 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
7.32 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0399 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0126 pure
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.84
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.74
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3154324 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3140284 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3111462 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3093877 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
42862 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
100089 usd
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
128990 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
86000 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
72000 usd
CY2022Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
385000 usd
CY2021Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
399000 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
471000 usd
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
471000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
471000 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
471000 usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
0 usd
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-55000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2022 skas Effective Income Tax Rate Reconciliation Extinguishment Of Debt
EffectiveIncomeTaxRateReconciliationExtinguishmentOfDebt
0 pure
CY2021 skas Effective Income Tax Rate Reconciliation Extinguishment Of Debt
EffectiveIncomeTaxRateReconciliationExtinguishmentOfDebt
-0.069 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Life Insurance
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLifeInsurance
0.117 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Life Insurance
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLifeInsurance
-0 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.127 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.059 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.220 pure
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.200 pure
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
975074
CY2022 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
1256
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
976330
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
53328
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.384
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
13332
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.450
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
6666
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
2.250
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
59994
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.184
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
20832
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.90
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3333
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.580
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
9999
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
3.240
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
67494
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.04
CY2022Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
67494
CY2022Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
46662
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
45238 usd
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
333306
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
333306
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
333306

Files In Submission

Name View Source Status
0001437749-23-010425-index-headers.html Edgar Link pending
0001437749-23-010425-index.html Edgar Link pending
0001437749-23-010425.txt Edgar Link pending
0001437749-23-010425-xbrl.zip Edgar Link pending
ex_499288.htm Edgar Link pending
ex_499289.htm Edgar Link pending
ex_499290.htm Edgar Link pending
ex_499291.htm Edgar Link pending
ex_499292.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
skas-20221231.xsd Edgar Link pending
skas20221231_10k.htm Edgar Link pending
skas-20221231_cal.xml Edgar Link unprocessable
skas-20221231_def.xml Edgar Link unprocessable
skas-20221231_pre.xml Edgar Link unprocessable
skas-20221231_lab.xml Edgar Link unprocessable
skas20221231_10k_htm.xml Edgar Link completed